Target type: biologicalprocess
The assembly of actin rods, a cellular structure consisting of parallel, hexagonally arranged actin tubules. [GOC:pg, PMID:14706699]
Actin rod assembly is a fundamental process in eukaryotic cells, essential for diverse cellular functions like cell migration, division, and maintaining cell shape. The process involves the polymerization of monomeric globular actin (G-actin) into filamentous actin (F-actin) to form rod-like structures. The formation of actin rods is regulated by a complex interplay of actin-binding proteins, including nucleators, capping proteins, and severing factors.
**Nucleation:** The initial step in actin rod assembly is the formation of a stable nucleus, typically a trimer of G-actin molecules. Nucleation is the rate-limiting step in actin polymerization and requires specific proteins called nucleators. These proteins, such as the Arp2/3 complex, formin, and Spire, provide a platform for G-actin monomers to bind and initiate the formation of the nucleus.
**Elongation:** Once the nucleus is formed, G-actin monomers add to both ends of the filament, a process called elongation. This step is driven by the inherent ability of G-actin to bind to other G-actin molecules and is further influenced by the concentration of free G-actin monomers. The plus end of the filament, also known as the barbed end, grows faster than the minus end, known as the pointed end.
**Capping:** To control the length of the actin rods, cells utilize capping proteins that bind to the ends of the filament. Capping proteins, such as CapZ and tropomodulin, prevent further addition of G-actin monomers to the ends, effectively capping the filament.
**Severing:** To regulate the length and organization of actin rods, cells use severing factors like cofilin. Cofilin binds to F-actin, destabilizing the filament and promoting its breakage into shorter fragments. This process allows for the recycling of actin and the generation of new filaments for further polymerization.
**Branching:** In many cell types, actin filaments form branched networks. The Arp2/3 complex is crucial for this process, as it binds to the side of existing filaments and nucleates the formation of new branches at a 70-degree angle. These branched networks provide structural support and create a dynamic cytoskeleton, allowing cells to respond to their environment and migrate.
**Regulation:** Actin rod assembly is tightly regulated by a complex interplay of signaling pathways, including those involving Rho GTPases. These small GTPases, such as Rho, Rac, and Cdc42, activate downstream effectors that influence the activity of actin-binding proteins, thereby controlling the dynamics of actin polymerization and the formation of specific actin structures.
**Conclusion:** The assembly of actin rods is a multifaceted process that is essential for diverse cellular functions. The intricate interplay of nucleators, capping proteins, severing factors, and regulatory pathways ensures that actin polymerization occurs in a controlled manner, leading to the formation of dynamic and functional actin structures.'
"
Protein | Definition | Taxonomy |
---|---|---|
Endoplasmin | An endoplasmin that is encoded in the genome of human. [PRO:DAN] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
adenosine diphosphate | Adenosine Diphosphate: Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite |
2-chloroadenosine | 5-chloroformycin A: structure given in first source | purine nucleoside | |
adenosine | quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
adenosine-5'-carboxylic acid | purine nucleoside | ||
adenosine 5'-carboxamide | adenosine 5'-carboxamide: structure | ||
5'-n-methylcarboxamideadenosine | 5'-N-methylcarboxamideadenosine: RN given refers to (beta-D)-isomer | ||
n-methyladenosine | N-methyladenosine: is a inhibitor of cell differentiation N(6)-methyladenosine : A methyladenosine compound with one methyl group attached to N(6) of the adenine nucleobase. | methyladenosine | |
ethyl adenosine-5'-carboxylate | ethyl adenosine-5'-carboxylate: potent vasoactive substance; RN given refers to parent cpd | ||
adenosine 5'-phosphoramidate | adenosine 5'-phosphoramidate : The phosphoramadite analogue of AMP. | organic phosphoramidate | Mycoplasma genitalium metabolite |
adenosine-5'-(n-ethylcarboxamide) | Adenosine-5'-(N-ethylcarboxamide): A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. N-ethyl-5'-carboxamidoadenosine : A derivative of adenosine in which the 5'-hydroxymethyl group is replaced by an N-ethylcarboxamido group. | adenosines; monocarboxylic acid amide | adenosine A1 receptor agonist; adenosine A2A receptor agonist; antineoplastic agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
adenosine-5'-(N-propyl)carboxamide | adenosine-5'-(N-propyl)carboxamide : A monocarboxylic acid amide that is the propyl amide of adenosine 5'-carboxylic acid. | adenosines; monocarboxylic acid amide | |
1-aminoadenosine | 1-aminoadenosine: structure | ||
9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)- | 9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-: an epichaperome (purine-scaffold) inhibitor; structure in first source | ||
5'-amino-5'-deoxyadenosine | |||
n-cyclopropyl adenosine-5'-carboxamide | |||
ec 144 | EC 144: structure in first source | ||
at 13387 | (2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone: structure in first source onalespib : A member of the class of isoindoles that is isoindole in which the amino group has been acylated by a 2,4-dihydroxy-5-isopropylbenzoyl group and in which position 5 of the isoidole moiety has been substituted by a (4-methylpiperazin-1-yl)methyl group. A second-generation Hsp90 inhibitor. | benzamides; isoindoles; N-alkylpiperazine; resorcinols; tertiary carboxamide | antineoplastic agent; Hsp90 inhibitor |
cnf 2024 | 2-aminopurines; aromatic ether; organochlorine compound; pyridines | antineoplastic agent; Hsp90 inhibitor | |
snx 2112 | SNX 2112: an orally available small molecule Hsp90 inhibitor; structure in first source | ||
tas-116 | |||
ver 52296 | luminespib : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-(2,4-dihydroxy-5-isopropylphenyl)-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxylic acid with the amino group of ethylamine. | aromatic amide; isoxazoles; monocarboxylic acid amide; morpholines; resorcinols | angiogenesis inhibitor; antineoplastic agent; Hsp90 inhibitor |
sta 9090 | ring assembly; triazoles |